CRISPR SCREENING USING HIGH-RESOLUTION MELTING
Source: CRISPR SCREENING USING HIGH-RESOLUTION MELTING
New genome editing tools such as the CRISPR system have greatly expanded the ability to modify genes, including creating single nucleotide polymorphisms (SNPs) and small indels, in different models. But the time and resources required to screen large numbers of cells to identify gene edited samples is a considerable bottleneck.
High-resolution melting (HRM) measures temperature variations with high precision as the DNA strands melt, with mutations being detected by analyzing melt curves. HRM limits the amount of sequencing required at each step, reducing the amount of resources required for both screening and sample preparation.
Find out how HRM can ease the arduous process of CRISPR screening with this infographic from Canon Biomedical!
Published at Mon, 26 Mar 2018 13:46:59 +0000
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.